1. Clinical ramifications of “genomic staging” of low-grade gliomas

   • Vivek Verma
   • Minesh P. Mehta

   Topic Review 11 July 2016 Pages: 195 - 199

2. Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo

   • Jai-Nien Tung
   • Chung-Po Ko
   • Kun-Chung Chen

   Laboratory Investigation 09 June 2016 Pages: 201 - 209

   

3. MicroRNA-132 targets PEA-15 and suppresses the progression of astrocytoma in vitro

   • Fei Geng
   • Jian-Lin Wu
   • Xi Gu

   Laboratory Investigation 13 June 2016 Pages: 211 - 220

   

4. Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma

   • Myra E. van Linde
   • Johannes C. van der Mijn
   • Henk M. W. Verheul

   Laboratory Investigation Open access 21 July 2016 Pages: 221 - 230

   

5. Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo

   • Tsutomu Nakazawa
   • Mitsutoshi Nakamura
   • Hiroyuki Nakase

   Laboratory Investigation 08 July 2016 Pages: 231 - 241

   

6. Stereotactic biopsy of brainstem lesions: 21 years experiences of a single center

   • Johanna Quick-Weller
   • Stephanie Lescher
   • Gerhard Marquardt

   Clinical Study 13 June 2016 Pages: 243 - 250

   

7. Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes

   • James E. Bates
   • Gyujae Choi
   • Michael T. Milano

   Clinical Study 15 June 2016 Pages: 251 - 258

   

8. Peritumoural glutamate correlates with post-operative seizures in supratentorial gliomas

   • Andrew Neal
   • Tanya Yuen
   • Andrew Morokoff

   Clinical Study 16 June 2016 Pages: 259 - 267

   

9. Does where you live influence how your vestibular schwannoma is managed? Examining geographical differences in vestibular schwannoma treatment across the United States

   • Matthew L. Carlson
   • Amy E. Glasgow
   • Michael J. Link

   Clinical Study 22 June 2016 Pages: 269 - 279

   

10. A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma

    • Kent C. Shih
    • Sajeel Chowdhary
    • John D. Hainsworth

    Clinical Study 16 June 2016 Pages: 281 - 288

    

11. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma

    • Guido H. Jajamovich
    • Chandni R. Valiathan
    • Sangeetha Somayajula

    Clinical Study 08 July 2016 Pages: 289 - 300

    

12. Ferumoxytol-enhanced MRI differentiation of meningioma from dural metastases: a pilot study with immunohistochemical observations

    • Bronwyn E. Hamilton
    • Randall L. Woltjer
    • Edward A. Neuwelt

    Clinical Study 08 July 2016 Pages: 301 - 309

    

13. Cognitive outcomes among survivors of focal low-grade brainstem tumors diagnosed in childhood

    • Kellie N. Clark
    • Jason M. Ashford
    • Heather M. Conklin

    Clinical Study 16 June 2016 Pages: 311 - 317

    

14. Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysis

    • Christine Jungk
    • Moritz Scherer
    • Andreas Unterberg

    Clinical Study Open access 25 June 2016 Pages: 319 - 328

    

15. Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors

    • Yurday Ozdemir
    • Berna Akkus Yildirim
    • Erkan Topkan

    Clinical Study 15 June 2016 Pages: 329 - 335

    

16. WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment

    • Charles Champeaux
    • Elena Wilson
    • Lewis Thorne

    Clinical Study 16 June 2016 Pages: 337 - 345

    

17. Role of irradiation for patients over 80 years old with glioblastoma: a retrospective cohort study

    • Stefano Bracci
    • Florence Laigle-Donadey
    • Loïc Feuvret

    Clinical Study 16 June 2016 Pages: 347 - 353

    

18. Alectinib’s activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series

    • Giulio Metro
    • Gianluigi Lunardi
    • Rita Chiari

    Clinical Study 20 June 2016 Pages: 355 - 361

    

19. The detectability of brain metastases using contrast-enhanced spin-echo or gradient-echo images: a systematic review and meta-analysis

    • Chong Hyun Suh
    • Seung Chai Jung
    • Junhee Pyo

    Clinical Study 20 June 2016 Pages: 363 - 371

    

20. Children with minimal chance for cure: parent proxy of the child’s health-related quality of life and the effect on parental physical and mental health during treatment

    • Belinda N. Mandrell
    • Justin Baker
    • Alberto Broniscer

    Clinical Study 25 June 2016 Pages: 373 - 381

21. Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India

    • Ravindra Pramod Deshpande
    • Deepak Babu
    • Phanithi Prakash Babu

    Letter to the Editor 16 June 2016 Pages: 383 - 387